AU5250400A - Osteogenesis promoters - Google Patents

Osteogenesis promoters

Info

Publication number: AU5250400A
Authority: AU; Australia
Prior art keywords: osteogenesis promoters; osteogenesis; promoters
Prior art date: 1999-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU52504/00A

Inventor

Kazuyuki Itoh

Hideki Yoshikawa

Kiyoko Yoshioka

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mitsubishi Pharma Corp

Original Assignee

Welfide Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-18

Filing date

2000-06-16

Publication date

2001-01-09

2000-06-16 Application filed by Welfide Corp filed Critical Welfide Corp

2001-01-09 Publication of AU5250400A publication Critical patent/AU5250400A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU52504/00A 1999-06-18 2000-06-16 Osteogenesis promoters Abandoned AU5250400A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP11/172330		1999-06-18
JP17233099		1999-06-18
PCT/JP2000/003969 WO2000078351A1 (en)	1999-06-18	2000-06-16	Osteogenesis promoters

Publications (1)

Publication Number	Publication Date
AU5250400A true AU5250400A (en)	2001-01-09

Family

ID=15939915

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU52504/00A Abandoned AU5250400A (en)	1999-06-18	2000-06-16	Osteogenesis promoters

Country Status (2)

Country	Link
AU (1)	AU5250400A (en)
WO (1)	WO2000078351A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5042419B2 (en) *	2001-08-15	2012-10-03	旭化成ファーマ株式会社	Bone formation promoter and composition for promoting bone formation
US7645878B2 (en)	2002-03-22	2010-01-12	Bayer Healthcare Llc	Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
EP1854484A4 (en) *	2005-02-16	2010-02-10	Astellas Pharma Inc	Pain remedy containing rock inhibitor
US8211919B2 (en)	2005-09-02	2012-07-03	Astellas Pharma Inc.	Amide derivatives as rock inhibitors
JPWO2010058679A1 (en) *	2008-11-18	2012-04-19	国立大学法人九州大学	Fracture repair accelerator
EP2398897B1 (en)	2009-02-20	2017-06-28	Cellular Dynamics International, Inc.	Methods and compositions for the differentiation of stem cells
AU2010217739B2 (en)	2009-02-27	2015-09-03	FUJIFILM Cellular Dynamics, Inc.	Differentiation of pluripotent cells
CN105861446B (en)	2009-10-16	2021-10-01	斯克里普斯研究所	Induction of pluripotent cells
EP2655601A4 (en)	2010-12-22	2014-09-10	Fate Therapeutics Inc	CELL CULTURE PLATFORM FOR ISOLATED CELL SORTING AND ENHANCED IPSC REPROGRAMMING
GB201107176D0 (en)	2011-04-28	2011-06-15	Cxr Biosciences Ltd	Pyrrolnitrin derivatives
WO2013163171A1 (en)	2012-04-24	2013-10-31	Kaufman Dan S	Method for developing natural killer cells from stem cells
CA2899507A1 (en)	2013-03-14	2014-09-25	The Regents Of The University Of California	In vitro production of medial ganglionic eminence precursor cells
WO2015134652A1 (en)	2014-03-04	2015-09-11	Bahram Valamehr	Improved reprogramming methods and cell culture platforms
EP4088719A1 (en)	2015-10-13	2022-11-16	Institut National de la Santé et de la Recherche Médicale (INSERM)	Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
WO2017064119A1 (en)	2015-10-13	2017-04-20	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
CN117737124A (en)	2015-10-16	2024-03-22	菲特治疗公司	Platform for inducing and maintaining ground state pluripotency
RU2628370C2 (en) *	2015-12-28	2017-08-16	Федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт травматологии и ортопедии имени Н.Н. Приорова" Министерства здравоохранения Российской Федерации (ФГБУ "ЦИТО им. Н.Н. Приорова" Минздрава России)	Method for heterotopic ossification surgical treatment with local neural simulation of spastic syndrome
WO2020193802A1 (en)	2019-03-28	2020-10-01	Fundación De La Comunidad Valenciana Centro De Investigación Príncipe Felipe	Polymeric conjugates and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5550134A (en) *	1995-05-10	1996-08-27	Eli Lilly And Company	Methods for inhibiting bone loss
US6008230A (en) *	1995-10-16	1999-12-28	Fujisawa Pharmaceutical Co., Ltd.	Quinoline compounds as H+ -ATPases
EP0866710A4 (en) *	1995-10-23	2001-07-11	Zymogenetics Inc	COMPOSITIONS AND METHODS FOR THE TREATMENT OF BONE DEFICITS
DE69737631T3 (en) *	1996-08-12	2011-08-18	Mitsubishi Tanabe Pharma Corp.	MEDICAMENTS CONTAINING Rho-KINASE INHIBITORS
AU4988997A (en) *	1996-10-23	1998-05-15	Osteoscreen, Inc.	Compositions and methods for treating bone deficit conditions

2000
- 2000-06-16 WO PCT/JP2000/003969 patent/WO2000078351A1/en active Application Filing
- 2000-06-16 AU AU52504/00A patent/AU5250400A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2000078351A1 (en)	2000-12-28

Publication	Publication Date	Title
AU5489099A (en)	2000-03-14	Seed-preferred promoters
AU1173201A (en)	2001-05-14	Skin-gripper
AU3092999A (en)	2000-10-04	Digital-timeshare-exchange
AU2001271434A1 (en)	2003-01-08	Novel skateboard-bicycle combination
AU5250400A (en)	2001-01-09	Osteogenesis promoters
AU6865100A (en)	2001-04-10	Osteogenesis promoting agents
AU2829600A (en)	2000-09-28	Osteogenesis promoters
AU2719500A (en)	2000-07-24	Seed-preferred promoter
AU4115400A (en)	2000-11-14	Short-circuiter
AU2023701A (en)	2001-06-18	Sketcher
AU2804600A (en)	2000-09-04	Arylaminoalkylamides
AU2699800A (en)	2000-09-04	Organoceramics
AU1887400A (en)	2000-07-24	Adhesion promoters
AU3968100A (en)	2000-11-02	Fixture unit
AU5824400A (en)	2001-04-17	Vascular-specific promoters
AU4916900A (en)	2000-12-05	Benzofuranylsulfonates
AU2359301A (en)	2001-06-04	Novel ss-defensins
AU7273000A (en)	2001-03-19	Novel processes
AU1038501A (en)	2001-04-30	Novel processes
AU4561600A (en)	2000-12-05	Benzofuranylaminoalcohols
AU2001260643A1 (en)	2002-02-28	Ectocornea extension promoters
AU4597100A (en)	2000-12-05	Senescence-related promoters
AU1901801A (en)	2001-05-30	Glucofuranoses
AU2939100A (en)	2000-09-28	Promoters
AU2273500A (en)	2000-08-25	Hand controller

Legal Events

Date	Code	Title	Description
2002-04-18	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase